ClinicalTrials.Veeva

Menu

Effects Of Caffeine On Cognitive Performance

U

University of Castilla-La Mancha

Status

Completed

Conditions

Caffeine

Treatments

Dietary Supplement: 3 mg/kg of caffeine
Dietary Supplement: PLACEBO
Dietary Supplement: 6 mg/kg of caffeine

Study type

Interventional

Funder types

Other

Identifiers

NCT05995314
CAF_MR_2023

Details and patient eligibility

About

Caffeine is a potent central nervous system stimulant that increases the activity in the prefrontal cortex and can improve cognitive skills. An improvement in these cognitive skills can lead to further benefits in athletic performance. Therefore, it is necessary to clarify the dose-response of caffeine on cognitive performance.The aim of this research will be to determine the effects of different doses of caffeine on sport-related cognitive aspects.

Full description

The investigators will require healthy, physically active young adults to complete three trials under the conditions: a) placebo, b) 3 mg/kg, or c) 6 mg/kg body mass of caffeine. In each trial, different cognitive abilities will be assessed using the following test batteries: reaction time (DynavisionTM D2), anticipation (Bassin Anticipation Timer), sustained attention (Go/No-Go and Eriksen Flanker Test) and memory tests. In addition, side effects and the perceived sensation index will be recorded 24 h after each test.

Enrollment

30 patients

Sex

All

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Physically active individuals ( >150 min/week moderate physical activity or >75 min/week vigorous physical activity)
  • Individuals without serious and undiagnosed health problems.

Exclusion criteria

  • Individuals with color blindness.
  • Regular caffeine consumers (>3 cups of coffee/day).

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

30 participants in 3 patient groups, including a placebo group

PLACEBO
Placebo Comparator group
Description:
placebo (0 mg/kg of body mass of caffeine). The capsule will be filled with 3 mg/kg of body mass of cellulose.
Treatment:
Dietary Supplement: PLACEBO
3mg/kg
Experimental group
Description:
3 mg/kg of body mass of caffeine (99% caffeine, Bulkpowders, United Kingdom).
Treatment:
Dietary Supplement: 3 mg/kg of caffeine
6mg/kg
Experimental group
Description:
6 mg/kg of body mass of caffeine (99% caffeine, Bulkpowders, United Kingdom).
Treatment:
Dietary Supplement: 6 mg/kg of caffeine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems